Catalyst Wire Dossier Catalyst Wire Dossier

tafluprost-timolol preservative-free fixed-dose combination

tafluprost timolol · Santen Oy
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for tafluprost-timolol preservative-free fixed-dose combination, covering 2013-03-13 to 2013-03-13. Get the full timeline:

Most recent: Clinical Trial Update: Tafluprost-Timolol Preservative-free Fixed Dose Combination (FDC) Superiority Study Against Monotherapies [Phase 3]

See pricing